Armando Santoro

Humanitas University — Italy

Medicine · Health Sciences

120h-index76.7kcitations1.8kworks4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(401), Lung Cancer Treatments and Mutations(266), Chronic Lymphocytic Leukemia Research(173), CAR-T cell therapy research(163), Colorectal Cancer Treatments and Studies(162)

Publications1.8k total

Tolerability and Clinical Benefit Assessment of Continuous Roginolisib Administration in Patients with Cancer including Metastatic Uveal Melanoma
2025Open Access
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching
Tumori Journal·2025
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
Future Oncology·2025Open Access
[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?
La radiologia medica·2025· 1 citedOpen Access
Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2025Open Access
Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2025Open Access
Supplementary Information 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2025Open Access
Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
2025Open Access
Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response
Critical Reviews in Oncology/Hematology·2025· 1 cited
Clinical and technological validation of locally-installed, privacy-compliant, and hematology-tailored ambient AI platform for clinical report transcription assistance and clinical trial patient management
Blood·2025Open Access
Rapid genomic analysis for the early identification of complement abnormalities in adults with transplant associated thrombotic microangiopathy
Blood·2025Open Access
Cytomegalovirus (CMV) reactivation negatively impacts survival after CAR T-cell therapy in lymphoma patients: Results from the CART-SIE study
Blood·2025
A FOXP3+ cell-rich microenvironment associates with better overall survival after CAR-T cell therapy in relapsed/refractory B-cell lymphoma
Cytotherapy·2025
Hbc-positive status for hepatis B virus does not affect CAR-T cell outcomes in lymphoma: Results from the CART-SIE study
Blood·2025Open Access
Single-cell multi-omics profiling reveals distinct patterns of clonal expansion and microenvironmental shifts associated with disease evolution in patients with Myelodysplastic Syndromes
Blood·2025Open Access
Subcutaneous cevostamab demonstrates manageable safety and clinically meaningful activity in Relapsed/Refractory multiple myeloma (RRMM): First results from the Phase Ib CAMMA 3 study
Blood·2025
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial
Blood Neoplasia·2025Open Access
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer
ESMO Open·2025Open Access
Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study
Journal for ImmunoTherapy of Cancer·2025Open Access
Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions
Cancers·2025· 3 citedOpen Access
page 1 of 92Next →

Frequent Co-authors

Massimo Roncalli(7), Jordi Bruix(5), Annarita Destro(5), Marco Alloisio(5), Vincenzo Mazzaferro(4), Camillo Porta(4), Luigi Bolondi(4), Johan Vansteenkiste(4), Brian Schwartz(4), Pier Luigi Zinzani(4), Federico Cappuzzo(4), Giovanna Finocchiaro(4), Marileila Varella‐Garcia(4), Gianni Bonadonna(4), Josep M. Llovet(3), M. Moscovici(3), D. Ross Camidge(3), Yoon‐Koo Kang(3), Anas Younes(3), Margaret A. Shipp(3)